Bristol-Myers Squibb Co (LIM:BMY)
$ 56.98 (0%) Market Cap: 115.79 Bil Enterprise Value: 151.76 Bil PE Ratio: 16.33 PB Ratio: 5.91 GF Score: 57/100

Bristol-Myers Squibb Co at Bank of America Global Healthcare Conference Transcript

May 14, 2026 / 03:40PM GMT
Release Date Price: $58.86
Jason Gerberry
Bofa Merrill Lynch Asset Holdings Inc - Analyst

All right, everybody. We're going to get going here with our next company presenter at the BofA Annual Healthcare Conference. My name is Jason Gerberry. I cover pharma and biotech, and I'm pleased to be introducing our next company presenter, Bristol-Myers Squibb, and Adam Lenkowsky, Executive VP and Chief Commercial Officer. So, Adam, thanks for joining us.

Adam Lenkowsky
Bristol-Myers Squibb Co - EVP, Chief Commercialization Officer

Thanks for having me, Jason.

Questions & Answers

Jason Gerberry
Bofa Merrill Lynch Asset Holdings Inc - Analyst

Yeah, so great. Look, there's a lot to talk about. I think Bristol is at an important inflection point as a company. You're rolling through some older franchises, but you've got a lot of pipeline on the come and some products that are early in their launch process. So I think we have a lot to talk about. Maybe coming out of 1Q, and as you kind of think about the growth portfolio specifically, maybe

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot